Skip to main content
logo
ResMed Inc. (LON:0KW4)
London flag London · Delayed Price · Currency is GBP · Price in USD
278.55
+2.63 (0.95%)
At close: Aug 1, 2025

SolarWinds Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B USD with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

Revenue
$5.15B
Revenue Growth
+9.84%
P/S Ratio
8.21
Revenue / Employee
$515.66K
Employees
9,980
Market Cap
30.86B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc31.63B
Haleon11.02B
Smith & Nephew4.64B
ConvaTec Group1.72B
Hikma Pharmaceuticals2.50B
HUTCHMED (China)503.39M
Oxford Nanopore Technologies183.19M
Revenue Rankings

ResMed News

More News